List of insiders holdings for Radius Health Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Rubric Capital Management LP Rosen David Efraim 10% Owner | 2022-08-12 12:06:22 | 0 8,642,271 | 8,642,271 | Form 4 |
EVNIN LUKE Former 10% stockholder | 2016-09-29 18:05:35 | 0 5,831,253 | 5,831,253 | Form 4 |
Nordic Bioscience Clinical Development VII A/S 10% Owner | 2014-01-06 15:51:06 | 5,025,540 0 | 5,025,540 | Form 13D |
GALAKATOS NICHOLAS SIMON NICHOLAS J III WHEELER KURT Former 10% stockholder | 2016-09-29 18:04:35 | 0 3,689,706 | 3,689,706 | Form 4 |
Fromkin Andrew J. President & CEO | 2013-11-18 13:51:29 | 2,427,133 0 | 2,427,133 | Form 4 |
MPM BioVentures IV LLC MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP DOMBKOWSKI ASHLEY L Greene William KAILIAN VAUGHN M Scopa James Paul St Peter Steven Vander Vort John 10% Owner | 2011-05-19 11:58:56 | 0 2,382,430 | 2,382,430 | Form 3 |
MPM BioVentures IV LLC Scopa James Paul MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP KAILIAN VAUGHN M Foley Todd Former 10% stockholder | 2016-09-29 18:03:16 | 0 2,141,547 | 2,141,547 | Form 4 |
BROOKSIDE CAPITAL MANAGEMENT LLC BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL PARTNERS FUND LP 10% Owner | 2017-02-14 10:09:40 | 1,643,001 0 | 1,643,001 | Form 13G |
WYZGA MICHAEL S Chief Executive Officer | 2012-06-22 11:42:57 | 1,530,000 0 | 1,530,000 | Form 4 |
HEALTHCARE VENTURES VII LP HealthCare Partners VII L.P. CAVANAUGH JAMES H LAWLOR AUGUSTINE LITTLECHILD JOHN W Mirabelli Christopher WERNER HAROLD R 10% Owner | 2015-01-28 18:45:57 | 1,367,780 0 | 1,367,780 | Form 13D |
BRENNER LOUIS MD Chief Medical Officer | 2012-09-28 10:30:41 | 1,192,100 0 | 1,192,100 | Form 4 |
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 10% Owner | 2015-02-25 17:15:59 | 1,000,000 0 | 1,000,000 | Form 13G |
Lyttle Cecil Richard President & C.E.O. | 2013-12-06 17:10:49 | 66,666 767,174 | 833,840 | Form 3 |
Healthcare Private Equity Limited Partnership 10% Owner | 2013-05-09 14:04:36 | 816,462 0 | 816,462 | Form 13D |
Ward Rob President & CEO | 2015-10-23 21:45:39 | 781,605 0 | 781,605 | Form 4 |
F2 Bioscience III L.P. F2 Bioscience GP Ltd. F2 Capital Ltd Priestley Katherine Globeways Holdings Ltd 10% Owner | 2015-01-20 21:17:19 | 360,091 0 | 360,091 | Form 13D |
F2 Bioscience IV L.P. F2 Bioscience IV GP Ltd. F2 Capital Ltd Priestley Katherine F2 Bio Ventures V L.P. F2 Bio Ventures GP Ltd. Globeways Holdings Ltd 10% Owner | 2015-01-20 21:17:34 | 360,091 0 | 360,091 | Form 13D |
F2 Bioscience IV L.P. F2 Bioscience IV GP Ltd. F2 Capital Ltd Priestley Katherine F2 Bio Ventures V L.P. F2 Bio Ventures GP Ltd. Globeways Holdings Ltd F2 Bioscience VI L.P. 10% Owner | 2015-01-20 21:17:34 | 360,091 0 | 360,091 | Form 13D |
Yates John Chief Medical Officer | 2014-02-19 16:53:39 | 300,000 0 | 300,000 | Form 4 |
Jovan-Embiricos Morana Director 10% Owner | 2015-01-20 16:17:20 | 0 267,786 | 267,786 | Form 4/A |
O'Dea Louis Sr. VP, Chief Medical Officer | 2011-11-08 21:56:08 | 262,636 0 | 262,636 | Form 4 |
MPM BioVentures IV LLC Scopa James Paul Vander Vort John MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP Foley Todd KAILIAN VAUGHN M 10% Owner | 2013-04-30 13:55:09 | 0 250,733 | 250,733 | Form 4 |
Ward Robert President & CEO | 2017-02-22 16:31:06 | 187,800 0 | 187,800 | Form 4 |
Durand Mark Chief Commercial Officer | 2014-06-09 20:41:34 | 175,438 0 | 175,438 | Form 4 |
Ipsen Pharma SAS Ipsen S.A. 10% Owner | 2011-06-23 11:19:27 | 173,260 0 | 173,260 | Form 13D |
MPM BioVentures IV LLC MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP Foley Todd KAILIAN VAUGHN M Scopa James Paul St Peter Steven Vander Vort John 10% Owner | 2011-12-16 17:23:06 | 0 114,537 | 114,537 | Form 4 |
Hoeiland Jesper President and CEO | 2020-02-24 17:56:20 | 107,000 0 | 107,000 | Form 4 |
MPM BIOVENTURES III LLC HENNER DENNIS MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III PARALLEL FUND L.P. MPM BIOVENTURES III GP L.P. MPM BIOVENTURES III L.P. MPM BIOVENTURES III-QP L.P. STEINMETZ MICHAEL Former 10% stockholder | 2018-08-30 16:06:05 | 100,000 0 | 100,000 | Form 13D |
Harvey Brian Nicholas Sr. VP and CFO | 2017-04-27 20:58:58 | 76,189 0 | 76,189 | Form 4 |
Hatzis-Schoch Brent Sr. VP, General Counsel | 2019-02-26 18:14:33 | 72,944 0 | 72,944 | Form 4 |
Franken Michael Sr. Vice President and CBO | 2012-06-19 14:14:35 | 70,000 0 | 70,000 | Form 4 |
Williams Gregory C. Chief Development Officer | 2018-02-15 19:49:55 | 60,000 0 | 60,000 | Form 4 |
HARRIS ALAN G Chief Medical Officer | 2014-12-19 17:04:05 | 50,000 0 | 50,000 | Form 4 |
Conley Mark William VP, Chief Financial Officer | 2022-03-17 16:35:21 | 50,000 0 | 50,000 | Form 4 |
FLEMING JONATHAN Director | 2011-12-16 17:08:45 | 0 49,127 | 49,127 | Form 4 |
Carmona Jose Chief Financial Officer | 2020-02-28 16:15:13 | 46,708 0 | 46,708 | Form 4 |
Purandare Dinesh SVP, Head of Global Oncology | 2017-02-22 16:28:53 | 35,000 0 | 35,000 | Form 4 |
Morris Charles Q Chief Medical Officer | 2020-02-28 16:15:18 | 33,744 0 | 33,744 | Form 4 |
Helwig Steven Principal Financial Officer | 2022-01-25 16:30:51 | 31,251 0 | 31,251 | Form 4 |
Stoner Elizabeth Director | 2014-12-19 17:03:05 | 30,000 0 | 30,000 | Form 4 |
Hopfield Jessica Director | 2020-02-24 17:57:23 | 28,300 0 | 28,300 | Form 4 |
GADICKE ANSBERT Director | 2017-02-22 16:25:25 | 27,500 0 | 27,500 | Form 4 |
AUERBACH ALAN H Director | 2017-02-22 16:22:08 | 27,500 0 | 27,500 | Form 4 |
Kelly Joseph Francis Sr. VP of Sales and Marketing | 2020-02-28 16:15:21 | 24,111 0 | 24,111 | Form 4 |
Graves Kurt Director | 2020-02-24 17:54:59 | 21,000 0 | 21,000 | Form 4 |
Muenchbach Martin Director | 2015-05-26 19:14:52 | 15,000 0 | 15,000 | Form 4 |
Rosenberg Anthony Director | 2020-02-28 16:15:17 | 12,401 0 | 12,401 | Form 4 |
Dolan Dan VP of Finance | 2020-11-10 18:32:20 | 12,000 0 | 12,000 | Form 4 |
Grausso Sal Chief Commercial Officer | 2021-02-26 16:36:59 | 11,709 0 | 11,709 | Form 4 |
Chopas James George Principal Finance Accounting | 2021-03-09 06:54:29 | 6,701 0 | 6,701 | Form 4 |
Snow David P. Chief Commercial Officer | 2018-02-06 17:13:54 | 6,448 0 | 6,448 | Form 5 |
Roychowdhury Debasish Director | 2019-04-12 16:14:11 | 5,500 0 | 5,500 | Form 4 |
Hattersley Gary Chief Scientific Officer | 2019-02-13 17:33:00 | 1,173 0 | 1,173 | Form 5 |
Fitzpatrick Lorraine A. Chief Medical Officer | 2019-02-13 17:30:48 | 989 0 | 989 | Form 5 |
BIOTECH TARGET N V BB BIOTECH AG 10% Owner | 2022-08-30 17:02:52 | 0 0 | 0 | Form 13D |
BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 2022-08-30 17:02:52 | 0 0 | 0 | Form 13D |
Lisa Susan Vissers Director | 2022-08-15 16:20:10 | 0 0 | 0 | Form 4 |
Hughes Owen Director | 2022-08-15 16:19:43 | 0 0 | 0 | Form 4 |
SANDERS MACHELLE Director | 2022-08-15 16:19:46 | 0 0 | 0 | Form 4 |
Shah Chhaya Chief Business Officer | 2022-08-15 16:19:20 | 0 0 | 0 | Form 4 |
FRIEDMAN CATHY Director | 2022-08-15 16:17:09 | 0 0 | 0 | Form 4 |
Dere Willard H Director | 2022-08-15 16:16:39 | 0 0 | 0 | Form 4 |
Jarrett Jennifer Director | 2022-08-15 16:16:10 | 0 0 | 0 | Form 4 |
GARNIER JEAN PIERRE Director | 2022-08-15 16:16:10 | 0 0 | 0 | Form 4 |
VON ESCHENBACH ANDREW C. Director | 2022-08-15 16:15:16 | 0 0 | 0 | Form 4 |
Holtschlag Danielle Vice President, Sales | 2022-08-15 16:14:43 | 0 0 | 0 | Form 4 |
Messersmith Elizabeth Senior Vice President | 2022-08-15 16:14:07 | 0 0 | 0 | Form 4 |
Martin G. Kelly CEO and President | 2022-08-15 16:13:34 | 0 0 | 0 | Form 4 |
Murphy Sean Director | 2022-08-15 16:14:07 | 0 0 | 0 | Form 4 |